
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
MiddleBrook Pharmaceuticals, Inc. (Nasdaq: MBRK) (formerly Advancis) is a pharmaceutical company focused on developing and commercializing anti-infective products that fulfill unmet medical needs. MiddleBrook currently markets KEFLEX, the immediate-release brand of cephalexin, and MOXATAG the first and only FDA-approved once-daily amoxicillin
Pharmaceuticals,anti-infective products,and antibiotics
Middlebrook pharmaceuticals, inc operates in the Pharmaceutical manufacturing industry.
Middlebrook pharmaceuticals, inc's revenue is 11m - 100m
Middlebrook pharmaceuticals, inc has 11 - 50 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.